Regulation of mammalian MOR-1 gene expression after chronic treatment with morphine

International Journal of Molecular Medicine

Volumn 30, Issue 6, 2012, Pages 1493-1497

  Prenus, Rose V ^a   Luscar, Ebens ^a   Zhu, Zhi Ping ^a   Badisa, Ramesh B ^a   Goodman, Carl B ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

opioid receptor; Morphine; Naloxone; Real time qRT PCR

Indexed keywords

MESSENGER RNA; MORPHINE SULFATE; MU 1 OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALOXONE; RETINOIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CHO CELL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOLECULAR CLONING; MORPHINE TOLERANCE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALGESICS, OPIOID; ANIMALS; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; GENE EXPRESSION REGULATION; HUMANS; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; RECEPTORS, OPIOID, MU; RNA, MESSENGER;

EID: 84869469548     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1132     Document Type: Article

References (23)

1. World Health Organization: Cancer Pain Relief. Geneva, 1986.
2. Collin E and Cesselin F: Neurobiological mechanisms of opioid tolerance and dependence. Clin Neuropharmacol 14: 465-488, 1991.
3. Zhu Z, Badisa RB, Palm DE, et al: Regulation of rat MOR-1 gene expression after chronic ICV administration of morphine. Mol Med Rep 5: 513-516, 2012.
4. Oliveira MT, Rego AC, Morgadinho MT, et al: Macedo: Toxic effects of opioid and stimulant drugs on undifferentiated PC12 cells. Ann NY Acad Sci USA 965: 487-496, 2002. (Pubitemid 34721996)
5. Loh HH and Smith AP: Molecular characterization of opioid receptors. Annu Rev Pharmacol Toxicol 30: 123-147, 1990.
6. Kreek MJ: Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases. Neurochem Res 21: 1469-1488, 1996.
7. Borgland SL: Acute opioid receptor desensitization and tolerance: is there a link? Clin Exp Pharmacol Physiol 28: 147-154, 2001.
8. Castelli MP, Melis M, Mameli M, et al: Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain. Brain Res Mol Brain Res 45: 149-153, 1997. (Pubitemid 27182237)
9. Cheung Y-T, Lau WK-W, Yu M-S, et al: Effects of all-transretinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 30: 127-135, 2009.
10. Zadina JE, Chang SL, Ge LJ, et al: Mu opiate receptor downregulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells. J Pharmacol Exp Ther 265: 254-262, 1993. (Pubitemid 23320968)
11. Yu VC, Hochhaus G, Chang FG, et al: Differentiation of human neuroblastoma cells: Marked potentiation of prostaglandin E-stimulated accumulation of cyclic AMP by retinoic acid. J Neurochem 51: 1892-1899, 1988. (Pubitemid 19010980)
12. Pahlman S, Ruusala AI, Abrahamsson L, et al: Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ 14: 135-144, 1984. (Pubitemid 14089031)
13. Levites Y, Youdim MB, Maor G, et al: Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 63: 21-29, 2002. (Pubitemid 34075289)
14. Levites Y, Amit T, Mandel S, et al: Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J 17: 952-954, 2003.
15. Xue S, Jia L and Jia J: Hypoxia and reoxygenation increased BACE1 mRNA and protein levels in human neuroblastoma SH-SY5Y cells. Neurosci Lett 405: 231-235, 2006. (Pubitemid 44209306)
16. Lee JH, Shin SY, Kim S, et al: Suppression of PTEN expression during aggregation with retinoic acid in P19 mouse embryonal carcinoma cells. Biochem Biophys Res Commun 347: 715-722, 2006. (Pubitemid 44092642)
17. Yu X, Mao X, Blake AD, et al: Morphine and endomorphins differentially regulate μ-opioid receptor mRNA in SH-SY5Y human neuroblastoma cells. J Pharmacol Exp Ther 306: 447-454, 2003. (Pubitemid 36886139)
18. Vesanen M, Salminen M, Wessman M, et al: Morphological differentiation of human SH-SY5Y neuroblastoma cells inhibits human immunodeficiency virus type 1 infection. J Gen Virol 75: 201-206, 1994. (Pubitemid 24033999)
19. Clagett-Dame M, McNeill EM and Muley PD: Role of all-trans retinoic acid in neurite outgrowth and axonal elongation. J Neurobiol 66: 739-756, 2006. (Pubitemid 43939197)
20. Yabaluri N and Medzihradsky F: Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling. Mol Pharmacol 52: 896-902, 1997. (Pubitemid 27484183)
21. Tao PL, Han KF, Wang SD, et al: Immunohistochemical evidence of down-regulation of mu-opioid receptor after chronic PL-017 in rats. Eur J Pharmacol 344: 137-142, 1998.
22. Yamamoto J, Kawamata T, Niiyama Y, et al: Downregulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain. Neuroscience 151: 843-853, 2008.
23. Xu H, Wang X, Zimmerman D, et al: Chronic morphine up-regulates Gα12 and cytoskeletal proteins in Chinese hamster ovary cells expressing the cloned μ-opioid receptor. J Pharmacol Exp Ther 315: 248-255, 2005. (Pubitemid 41380518)